Compare Stocks: CDNA vs. ADPT vs. BDSX vs. IMDX
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
CDNAADPTBDSXIMDX
Market Snapshot
Current market context for the selected companies.
CDNA
$49.85
Market Cap
$2.58B
Sector
Healthcare
Industry
Diagnostics & Research
Data through
2026-09-03
ADPT
$24.55
Market Cap
$3.92B
Sector
Healthcare
Industry
Diagnostics & Research
Data through
2026-09-03
BDSX
$26.47
Market Cap
$279.34M
Sector
Healthcare
Industry
Diagnostics & Research
Data through
2026-09-03
IMDX
$4.15
Market Cap
$134.82M
Sector
Healthcare
Industry
Diagnostics & Research
Data through
2026-09-03
Performance
Absolute returns and relative performance versus SPY.
| Metric | CDNA | ADPT | BDSX | IMDX |
|---|---|---|---|---|
| 1 Month | +9.6% | -0.2% | +16.2% | -17.0% |
| 1 Month vs SPY | +9.2% | -0.6% | +15.8% | -17.4% |
| 3 Months | +115.6% | +35.8% | +60.4% | -36.6% |
| 3 Months vs SPY | +113.5% | +33.7% | +58.4% | -38.7% |
| 6 Months | +165.9% | +54.1% | +66.9% | -24.3% |
| 6 Months vs SPY | +152.4% | +40.7% | +53.5% | -37.7% |
| 1 Year | +291.6% | +91.1% | +213.6% | +62.1% |
| 1 Year vs SPY | +271.6% | +71.1% | +193.6% | +42.1% |
| 2 Years | +61.3% | +425.8% | -28.5% | +32.0% |
| 2 Years vs SPY | +22.9% | +387.4% | -66.9% | -6.4% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.